The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide

Arthritis and Rheumatism

Volumn 46, Issue 10, 2002, Pages 2637-2647

  Boileau, Christelle ^a   Martel Pelletier, Johanne ^a   Moldovan, Florina ^a   Jouzeau, Jean Yves ^b   Netter, Patrick ^b   Manning, Pamela T ^c   Pelletier, Jean Pierre ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b Biopôle de l Université de Lorraine   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1 CONVERTING ENZYME; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N IMINOETHYLLYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEINASE INHIBITOR; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; ENZYME ACTIVATION; ENZYME INHIBITION; FEMUR CONDYLE; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; CARTILAGE; CASPASE 1; CHONDROCYTES; DOGS; ENZYME ACTIVATION; INTERLEUKIN-18; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS; SERPINS; UP-REGULATION;

EID: 0036822533     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10518     Document Type: Article

References (38)

1. Pelletier JP, Martel-Pelletier J, Howell DS. Etiopathogenesis of osteoarthritis. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Baltimore: Williams & Wilkins; 2000. p. 2195-245.
2. Martel-Pelletier J, Di Battista JA, Lajeunesse D. Biochemical factors in joint articular tissue degradation in osteoarthritis. In: Reginster JY, Pelletier JP, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag; 1999. p. 156-87.
3. Amin AR, Dave M, Attur M, Abramson SB. COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2000;2:447-53.
4. Clancy R, Rediske J, Koehne C, Stoyanovsky D, Amin A, Attur M, et al. Activation of stress-activated protein kinase in osteoarthritic cartilage: evidence for nitric oxide dependence. Osteoarthritis Cartilage 2001;9:294-9.
5. Nishida K, Doi T, Matsuo M, Ishiwari Y, Tsujigiwa H, Yoshida A, et al. Involvement of nitric oxide in chondrocyte cell death in chondro-osteophyte formation. Osteoarthritis Cartilage 2001;9:232-7.
6. Pelletier J-P, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
7. Pelletier J-P, Jovanovic DV, Lascau-Coman V, Fernandes JC, Manning PT, Connor JR, et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 2000;43:1290-9.
8. Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 1998;10:263-8.
9. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 1999;7:377-9.
10. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 1999;25:269-82.
11. Amin AR, Di Cesare PE, Vyas P, Attur MG, Tzeng E, Billiar TR, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for an inducible "neuronal-like" nitric oxide synthase. J Exp Med 1995;182:2097-102.
12. Pelletier JP, Mineau F, Ranger P, Tardif G, Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996;4:77-84.
13. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
14. Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Currie MG, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999;26:2002-14.
15. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
16. Järvinen TAH, Moilanen T, Järvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995;4:107-11.
17. Taskiran D, Stefanovic-Racic M, Georgescu HI, Evans CH. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 1994;200:142-8.
18. Pelletier J-P, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
19. McInnes IB, Gracie JA, Liew FY. Interleukin-18: a novel cytokine in inflammatory rheumatic disease. Arthritis Rheum 2001;44:1481-3.
20. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, et al. Overview of interleukin-18: more than an interferon-γ inducing factor. J Leukoc Biol 1998;63:658-64.
21. Saha N, Moldovan F, Tardif G, Pelletier J-P, Cloutier J-M, Martel-Pelletier J. Interleukin-1β-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1β and interleukin-18. Arthritis Rheum 1999;42:1577-87.
22. Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999;162:1096-100.
23. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
24. Wei XQ, Leung BP, Arthur HM, McInnes IB, Liew FY. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 2001;166:517-21.
25. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T, et al. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem 1997;272:26595-603.
26. Miller DK, Ayala JM, Egger LA, Raju SM, Yamin TT, Ding GJ, et al. Purification and characterization of active human interleukin-1β-converting enzyme from THP.1 monocytic cells. J Biol Chem 1993;268:18062-9.
27. Fantuzzi G, Dinarello CA. Interleukin-18 and interleukin-1β: two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999;19:1-11.
28. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, et al. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994;370:270-5.
29. Ramage P, Cheneval D, Chvei M, Graff P, Hemmig R, Heng R, et al. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1β-converting enzyme precursor. J Biol Chem 1995;270:9378-83.
30. Dinarello CA. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme. Ann NY Acad Sci 1998;856:1-11.
31. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-23.
32. , Annand RR, Dahlen JR, Sprecher CA, De Dreu P, Foster DC, Mankovich JA, et al. Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 1999;342 Pt 3:655-65.
33. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 2000;191:1535-44.
34. Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel-Pelletier J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of COX-2 and iNOS J. Rheumatol 2001;28:2509-19.
35. Rediske J, Koehne CF, Zhang B, Lotz M. The inducible production of nitric oxide by articular cell types. Osteoarthritis Cart 1994;2:199-206.
36. Presle N, Cipolletta C, Jouzeau JY, Abid A, Netter P, Terlain B. Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1β in rats. Arthritis Rheum 1999;42:2094-102.
37. Moldovan F, Pelletier JP, Jolicoeur FC, Cloutier JM, Martel-Pelletier J. Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000;8:186-96.
38. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000;43:801-11.